Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 1998

View Archived Issues

Roche now supplying antiobesity drug in several new markets

Aradigm licenses new aerosol technology from Spanish university

Licensing opportunity from BTG: topically active 5-LO inhibitor for psoriasis

Biogen: Q3 1998 highlights

Licensing opportunity from BTG: 12(R)-HETE formation inhibitor for psoriasis

Dronedarone preclinical data: electrophysiological, hemodynamic and antiarrhythmic effects in dogs

Millennium BioTherapeutics to use Abgenix human antibody technology

Phase I trial for Anergen multiple sclerosis compound demonstrates safety

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Yamanouchi applies for approval of oral bisphosphonate in Japan

HMG-CoA reductase inhibitor now under regulatory review in Japan

SkyePharma may acquire DepoTech

Cephems from Zenyaku Kogyo with improved activity compared to flomoxef, vancomycin

Daiichi's new squalene synthase inhibitors

Propionic acid derivatives from Nippon Chemiphar useful for diabetes and related disorders

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Milkhaus successfully completes phase II trial of BPH therapeutic

Knoll terminates verapamil collaboration with Chiroscience; company seeks new partners

U.S. launch announced for Atacand

MorphiDex NDA accepted for FDA review

Overview of studies on SDZ-ASM-981, a potential new gold standard in treating atopic dermatitis

Versed Syrup approved for pediatric sedation

Linoladiol cream: a novel approach to treating acne

Photoprotective efficacy obtained with topical application of vitamin C

Optimal dosing regimen defined for OCT in dose-finding studies

Novel orally active iron chelator presented by Novartis researchers

Linopirdine analogue proves to be more potent neurotransmitter release enhancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...